Effects of antidepressants on behavioral assessment in adolescent rats

Bahrain Medical Bulletin

Volumn 33, Issue 2, 2011, Pages

  El Refaey, Hesham ^a,b   Amri, Hasan S ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; IMIPRAMINE;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CLIMBING; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FORCED SWIMMING TEST; MALE; NONHUMAN; OPEN FIELD TEST; RAT;

EID: 79957888003     PISSN: 10128298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Porsolt RD. Animal Model of Depression. Biomedicine 1979; 30: 139-40.
2. Wen-Huang P, Kuan-Lin L, Yi-Hsuen L, et al. Berberine Produces Antidepressant-Like Effects in the Forced Swim Test and in the Tail Suspension Test in Mice. Life Sciences 2007; 81: 933-8.
3. Borsini F, Volterra G, Meli A. Does the Behavioral Despair Test Measure Despair? Physiol Behav 1986; 38: 385-6.
4. Borsini F, Lecci A, Sessarego A, et al. Discovery of Antidepressant Activity by Forced Swimming Test May Depend on Pre-exposure of Rats to a Stressful Situation. Psychopharmacology 1989; 97: 183-8.
5. Lucki I. The Forced Swimming Test as a Model for Core and Component Behavioral Effects of Antidepressant Drugs. Behav Pharmacol 1997; 8: 523-32.
6. Cryan JF, Markou A, Lucki I. Assessing Antidepressant Activity in Rodents: Recent Developments and Future Needs. Trends Pharmacol Sci 2002; 23: 238-45.
7. Nestler EJ, Gould E, Manji H, et al. Preclinical Models: Status of Basic Research in Depression. Biol Psychiatry 2002; 52: 503-28.
8. Detke MJ, Lucki I. Detection of Serotonergic and Noradrenergic Antidepressants in the Rat Forced Swimming Test: The Effects of Water Depth. Behav Brain Res 1996; 73: 43-46.
9. Detke MJ, Rickels M, Lucki I. Active Behaviors in the Rat Forced Swimming Test Differentially Produced by Serotonergic and Noradrenergic Antidepressants. Psychopharmacology (Berl) 1995; 121: 66-72.
10. Birmaher B, Ryan ND, Williamson DE, et al. Childhood and Adolescent Depression: A Review of the Past 10 Years-Part I. J Am Acad Child Adolesc.Psychiatry 1996; 35: 1427-39.
11. Lewinsohn PM, Clarke GN, Seeley JR, et al. Major Depression in Community Adolescents: Age at Onset, Episode Duration, and Time to Recurrence. J Am Acad Child Adolesc Psychiatry 1994; 33: 809-18.
12. Kessler RC, Avenevoli S, Ries Merikangas K. Mood Disorders in Children and Adolescents: An Epidemiologic Perspective. Biol Psychiatry 2001; 49: 1002-14.
13. Kovacs M, Goldston D, Gatsonis C. Suicidal Behaviors and Childhood-Onset Depressive Disorders: A Longitudinal Investigation. J Am Acad Child Adolesc Psychiatry 1993; 32: 8-20.
14. Weissman MM, Wolk S, Goldstein RB, et al. Depressed Adolescents Grown Up. JAMA 1999; 281: 1707-13.
15. McCauley E, Myers K, Mitchell J, et al. Depression in Young People: Initial Presentation and Clinical Course. J Am Acad Child Adolesc Psychiatry 1993; 32: 714-22.
16. Mitchell J, McCauley E, Burke PM, et al. Phenomenology of Depression in Children and Adolescents. J Am Acad Child Adolesc Psychiatry 1988; 27: 12-20.
17. Lee Fu-I, Yuan Pang W. Comparison of Demographic and Clinical Characteristics between Children and Adolescents with Major Depressive Disorder. Rev Bras Psiquiatr 2008; 30(2): 124-31.
18. Spear LP. The Adolescent Brain and Age-Related Behavioral Manifestations. Neurosci Biobehav Rev 2000; 24: 417-63.
19. Abel EL, Bilitzke PJ. A Possible Alarm Substance in the Forced Swimming Test. Physiol Behav 1990; 48: 233-9.
20. Kraemer HC, Periyakoil VS, Noda A. Tutorial in Biostatistics: Kappa Coefficients in Medical Research. Stat Med 2002; 21: 2109-29.
21. Deupree JD, Reed AL, Bylund DB. Differential Effects of the Tricyclic Antidepressant Desipramine on the Density of Adrenergic Receptors in Juvenile and Adult Rats. J Pharmacol Exp Ther 2007; 321: 770-6.
22. Murrin LC, Sanders JD, Bylund DB. Comparison of the Maturation of the Adrenergic and Serotonergic Neurotransmitter Systems in the Brain: Implications for Differential Drug Effects on Juveniles and Adults. Biochem Pharmacol 2007; 73: 1225-36.
23. Abel EL. Behavioral and Physiological Effects of Different Water Depths in the Forced Swim Test. Physiol Behav 1994; 56: 411-4.
24. Sunal R, Gumusel B, Kayaalp SO. Effect of Changes in Swimming Area on Results of Behavioral Despair Test. Pharmacol Biochem Behav 1994; 49: 891-6.
25. Reneric JP, Lucki I. Antidepressant Behavioral Effects by Dual Inhibition of Monoamine Reuptake in the Rat Forced Swimming Test. Psychopharmacology (Berl) 1998; 136: 190-7.
26. Deupree JD, Montgomery MD, Bylund DB. Pharmacological Properties of the Active Metabolites of the Antidepressants Desipramine and Citalopram. Eur J Pharmacol 2007; 576(1-3): 55-60.
27. Owens MJ, Morgan WN, Plott SJ, et al. Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites. J Pharmacol Exp Ther 1997; 283: 1305-22.
28. Cryan JF, Valentino RJ, Lucki I. Assessing Substrates Underlying the Behavioral Effects of Antidepressants Using the Modified Rat Forced Swimming Test. Neurosc Biobehav Rev 2005; 29: 547-69.
29. Frazer A. Serotonergic and Noradrenergic Reuptake Inhibitors: Prediction of Clinical Effects from in Vitro Potencies. J Clin Psychiatry 2001; 62(Suppl 12): 16-23.
30. Hooks MS, Jones DN, Holtzman SG, et al. Individual Differences in Behavior Following Amphetamine, GBR-12909, or Apomorphine but Not SKF-38393 or Quinpirole. Psychopharmacology (Berl) 1994; 116: 217-25.
31. Li SM, Collins GT, Paul NM, et al. Yawning and Locomotor Behavior Induced by Dopamine Receptor Agonists in Mice and Rats. Behav Pharmacol 2010; 21(3): 171-81.
32. Kozisek ME, Deupree JD, Burke WJ, et al. Appropriate Dosing Regimens for Treating Juvenile Rats with Desipramine for Neuropharmacological and Behavioral Studies. J Neurosci Methods 2007; 163: 83-91.
33. Mague SD, Pliakas AM, Todtenkopf MS, et al. Antidepressant-Like Effects of Kappa-Opioid Receptor Antagonists in the Forced Swim Test in Rats. J Pharmacol Exp Ther 2003; 305: 323-30.
34. Bridge JA, Iyengar S, Salary CB, et al. Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment: A Meta-Analysis of Randomized Controlled Trials. JAMA 2007; 297: 1683-96.
35. Whittington CJ, Kendall T, Fonagy P, et al. Selective Serotonin Reuptake Inhibitors in Childhood Depression: Systematic Review of Published versus Unpublished Data. Lancet 2004; 363: 1341-5.
36. Ambrosini PJ. A Review of Pharmacotherapy of Major Depression in Children and Adolescents. Psychiatr Serv 2000; 51: 627-33.
37. Skaer TL, Sclar DA, Robison LM. Trends in Prescriptions for Antidepressant Pharmacotherapy among US Children and Adolescents Diagnosed with Depression, 1990 through 2001: An Assessment of Accordance with Treatment Recommendations from the American Academy of Child and Adolescent Psychiatry. Clin Ther 2009; 31(1): 1478-87.
38. Hazell P, O'Connell D, Heathcote D, et al. Tricyclic Drugs for Depression in Children and Adolescents. Cochrane Database Syst Rev 2000; CD002317.
39. Leonard BE. Stress, Norepinephrine and Depression. J Psychiatry Neurosci 2001; 26(Suppl): S11-6.
40. Lenroot RK, Giedd JN. Brain Development in Children and Adolescents: Insights from Anatomical Magnetic Resonance Imaging. Neurosci Biobehav Rev 2006; 30: 718-29.
41. Brunello N, Mendlewicz J, Kasper S, et al. The Role of Noradrenaline and Selective Noradrenaline Reuptake Inhibition in Depression. Eur Neuropsychopharmacol 2002; 12: 461-75.
42. Lucki I, O'Leary OF. Distinguishing Roles for Norepinephrine and Serotonin in the Behavioral Effects of Antidepressant Drugs. J Clin Psychiatry 2004; 65(Suppl 4):11-24.